LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer
Eligible for screening study DCP 001
Montana Cancer Consortium will not be participating in the ICAREdata® project in this protocol.